Which has preferable earnings & valuation, EDR or GENI?

Egdon Resources has higher revenue and earnings than GENinCode. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Egdon Resources £8.08M 0.00 £2.51M N/A N/A GENinCode £3.08M 2.20 -£6.10M -£2.08 N/A

Is EDR or GENI more profitable?

Egdon Resources has a net margin of 31.06% compared to GENinCode's net margin of -185.47%. Egdon Resources' return on equity of 8.26% beat GENinCode's return on equity. Company Net Margins Return on Equity Return on Assets Egdon Resources 31.06% 8.26% 4.22% GENinCode -185.47% -409.40% -63.99%

Is DIS or GENI more profitable?

Distil has a net margin of -126.58% compared to GENinCode's net margin of -185.47%. Distil's return on equity of -21.81% beat GENinCode's return on equity. Company Net Margins Return on Equity Return on Assets Distil -126.58% -21.81% -7.50% GENinCode -185.47% -409.40% -63.99%

Which has preferable valuation & earnings, GENI or AMC?

Amur Minerals has lower revenue, but higher earnings than GENinCode. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GENinCode £3.08M 2.20 -£6.10M -£2.08 N/A Amur Minerals N/A N/A -£2.39M N/A N/A

Is GENI or AMC more profitable?

Amur Minerals has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Amur Minerals' return on equity of -14.97% beat GENinCode's return on equity. Company Net Margins Return on Equity Return on Assets GENinCode -185.47% -409.40% -63.99% Amur Minerals N/A -14.97% -7.77%

Which has better earnings & valuation, LION or GENI?

Lionsgold has higher earnings, but lower revenue than GENinCode. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lionsgold N/A N/A N/A N/A N/A GENinCode £3.08M 2.20 -£6.10M -£2.08 N/A

Is LION or GENI more profitable?

Lionsgold has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Lionsgold's return on equity of 0.00% beat GENinCode's return on equity. Company Net Margins Return on Equity Return on Assets Lionsgold N/A N/A N/A GENinCode -185.47% -409.40% -63.99%

Which has higher valuation & earnings, GENI or SPHR?

Sphere Medical has lower revenue, but higher earnings than GENinCode. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GENinCode £3.08M 2.20 -£6.10M -£2.08 N/A Sphere Medical N/A N/A N/A N/A N/A

Does the media favor GENI or SPHR?

In the previous week, GENinCode and GENinCode both had 1 articles in the media. Sphere Medical's average media sentiment score of 1.52 beat GENinCode's score of 1.27 indicating that Sphere Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GENinCode 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sphere Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

GENinCode (GENI) Competitors

GBX 0.94 +0.01 (+0.54%)

As of 07/3/2026 10:03 AM Eastern

Compare

GENI vs. EDR, DIS, AMC, LION, and SPHR

Should you buy GENinCode stock or one of its competitors? MarketBeat compares GENinCode with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GENinCode include Egdon Resources (EDR), Distil (DIS), Amur Minerals (AMC), Lionsgold (LION), and Sphere Medical (SPHR). These companies are all part of the "entertainment" industry.

How does GENinCode compare to Egdon Resources?

Egdon Resources (LON:EDR) and GENinCode (LON:GENI) are both small-cap entertainment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Egdon Resources has higher revenue and earnings than GENinCode.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Egdon Resources	£8.08M	0.00	£2.51M	N/A	N/A
GENinCode	£3.08M	2.20	-£6.10M	-£2.08	N/A

Egdon Resources has a net margin of 31.06% compared to GENinCode's net margin of -185.47%. Egdon Resources' return on equity of 8.26% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Egdon Resources	31.06%	8.26%	4.22%
GENinCode	-185.47%	-409.40%	-63.99%

Egdon Resources has a beta of -0.25, meaning that its share price is 125% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.588, meaning that its share price is 41% less volatile than the broader market.

In the previous week, GENinCode had 1 more articles in the media than Egdon Resources. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Egdon Resources. GENinCode's average media sentiment score of 1.27 beat Egdon Resources' score of 0.00 indicating that GENinCode is being referred to more favorably in the news media.

Company	Overall Sentiment
Egdon Resources	Neutral
GENinCode	Positive

18.6% of Egdon Resources shares are owned by institutional investors. Comparatively, 4.5% of GENinCode shares are owned by institutional investors. 63.8% of Egdon Resources shares are owned by insiders. Comparatively, 8.7% of GENinCode shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Egdon Resources beats GENinCode on 8 of the 11 factors compared between the two stocks.

How does GENinCode compare to Distil?

Distil (LON:DIS) and GENinCode (LON:GENI) are both small-cap entertainment companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

0.0% of Distil shares are held by institutional investors. Comparatively, 4.5% of GENinCode shares are held by institutional investors. 22.8% of Distil shares are held by company insiders. Comparatively, 8.7% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Distil has a net margin of -126.58% compared to GENinCode's net margin of -185.47%. Distil's return on equity of -21.81% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Distil	-126.58%	-21.81%	-7.50%
GENinCode	-185.47%	-409.40%	-63.99%

Distil has a beta of 0.916, suggesting that its share price is 8% less volatile than the broader market. Comparatively, GENinCode has a beta of 0.588, suggesting that its share price is 41% less volatile than the broader market.

In the previous week, GENinCode had 1 more articles in the media than Distil. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Distil. GENinCode's average media sentiment score of 1.27 beat Distil's score of 0.00 indicating that GENinCode is being referred to more favorably in the news media.

Company	Overall Sentiment
Distil	Neutral
GENinCode	Positive

Distil has higher earnings, but lower revenue than GENinCode. Distil is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Distil	£963K	1.12	-£2.19M	-£0.08	N/A
GENinCode	£3.08M	2.20	-£6.10M	-£2.08	N/A

Summary

Distil beats GENinCode on 7 of the 13 factors compared between the two stocks.

How does GENinCode compare to Amur Minerals?

GENinCode (LON:GENI) and Amur Minerals (LON:AMC) are both small-cap entertainment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

GENinCode has a beta of 0.588, suggesting that its share price is 41% less volatile than the broader market. Comparatively, Amur Minerals has a beta of 0.3, suggesting that its share price is 70% less volatile than the broader market.

Amur Minerals has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Amur Minerals' return on equity of -14.97% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	-185.47%	-409.40%	-63.99%
Amur Minerals	N/A	-14.97%	-7.77%

Amur Minerals has lower revenue, but higher earnings than GENinCode.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£3.08M	2.20	-£6.10M	-£2.08	N/A
Amur Minerals	N/A	N/A	-£2.39M	N/A	N/A

In the previous week, GENinCode had 1 more articles in the media than Amur Minerals. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Amur Minerals. GENinCode's average media sentiment score of 1.27 beat Amur Minerals' score of 0.00 indicating that GENinCode is being referred to more favorably in the media.

Company	Overall Sentiment
GENinCode	Positive
Amur Minerals	Neutral

4.5% of GENinCode shares are owned by institutional investors. 8.7% of GENinCode shares are owned by company insiders. Comparatively, 1.5% of Amur Minerals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

GENinCode beats Amur Minerals on 7 of the 11 factors compared between the two stocks.

How does GENinCode compare to Lionsgold?

Lionsgold (LON:LION) and GENinCode (LON:GENI) are both entertainment companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

In the previous week, GENinCode had 1 more articles in the media than Lionsgold. MarketBeat recorded 1 mentions for GENinCode and 0 mentions for Lionsgold. GENinCode's average media sentiment score of 1.27 beat Lionsgold's score of 0.00 indicating that GENinCode is being referred to more favorably in the news media.

Company	Overall Sentiment
Lionsgold	Neutral
GENinCode	Positive

Lionsgold has higher earnings, but lower revenue than GENinCode.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lionsgold	N/A	N/A	N/A	N/A	N/A
GENinCode	£3.08M	2.20	-£6.10M	-£2.08	N/A

4.5% of GENinCode shares are owned by institutional investors. 8.7% of GENinCode shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Lionsgold has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Lionsgold's return on equity of 0.00% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lionsgold	N/A	N/A	N/A
GENinCode	-185.47%	-409.40%	-63.99%

Summary

GENinCode beats Lionsgold on 5 of the 8 factors compared between the two stocks.

How does GENinCode compare to Sphere Medical?

GENinCode (LON:GENI) and Sphere Medical (LON:SPHR) are both entertainment companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

4.5% of GENinCode shares are held by institutional investors. 8.7% of GENinCode shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, GENinCode and GENinCode both had 1 articles in the media. Sphere Medical's average media sentiment score of 1.52 beat GENinCode's score of 1.27 indicating that Sphere Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GENinCode	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sphere Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Sphere Medical has lower revenue, but higher earnings than GENinCode.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GENinCode	£3.08M	2.20	-£6.10M	-£2.08	N/A
Sphere Medical	N/A	N/A	N/A	N/A	N/A

Sphere Medical has a net margin of 0.00% compared to GENinCode's net margin of -185.47%. Sphere Medical's return on equity of 0.00% beat GENinCode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GENinCode	-185.47%	-409.40%	-63.99%
Sphere Medical	N/A	N/A	N/A

Summary

Sphere Medical beats GENinCode on 4 of the 7 factors compared between the two stocks.

Get GENinCode News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GENI vs. The Competition

Export

Metric	GENinCode	Diagnostics & Research Industry	Medical Sector	LON Exchange
Market Cap	£6.78M	£653.79M	£7.16B	£2.74B
Dividend Yield	N/A	3.37%	2.66%	6.14%
P/E Ratio	-0.45	78.59	28.02	368.96
Price / Sales	2.20	617.86	540.37	85,974.71
Price / Cash	0.83	11.42	49.26	27.87
Price / Book	0.57	3.26	10.96	7.75
Net Income	-£6.10M	£334.07B	£3.57B	£5.89B
7 Day Performance	-0.53%	2.25%	2.12%	0.55%
1 Month Performance	-20.09%	-0.35%	5.25%	-0.34%
1 Year Performance	-58.44%	7.27%	33.29%	70.53%

GENinCode Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GENI GENinCode	N/A	GBX 0.94 +0.5%	N/A	-60.0%	£6.78M	£3.08M	N/A	2,300	Positive News Gap Down
EDR Egdon Resources	N/A	N/A	N/A	N/A	£24.88M	£8.08M	220.00	11,000
DIS Distil	N/A	GBX 0.07 +16.7%	N/A	-77.0%	£1.42M	£963K	N/A	220,000	Gap Down
AMC Amur Minerals	N/A	N/A	N/A	N/A	£1.25M	N/A	N/A	33,700
LION Lionsgold	N/A	N/A	N/A	N/A	£0.00	N/A	N/A	2,021

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:GENI) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GENinCode (GENI) Competitors

GENI vs. EDR, DIS, AMC, LION, and SPHR

How does GENinCode compare to Egdon Resources?

Summary

How does GENinCode compare to Distil?

Summary

How does GENinCode compare to Amur Minerals?

Summary

How does GENinCode compare to Lionsgold?

Summary

How does GENinCode compare to Sphere Medical?

Summary

Media Sentiment Over Time

GENI vs. The Competition

GENinCode Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

GENinCode (GENI) Competitors

GENI vs. EDR, DIS, AMC, LION, and SPHR

How does GENinCode compare to Egdon Resources?

Which has preferable earnings & valuation, EDR or GENI?

Is EDR or GENI more profitable?

Which has more risk and volatility, EDR or GENI?

Does the media refer more to EDR or GENI?

Do institutionals and insiders have more ownership in EDR or GENI?

Summary

How does GENinCode compare to Distil?

Do insiders and institutionals have more ownership in DIS or GENI?

Is DIS or GENI more profitable?

Which has more risk and volatility, DIS or GENI?

Does the media prefer DIS or GENI?

Which has higher earnings and valuation, DIS or GENI?

Summary

How does GENinCode compare to Amur Minerals?

Which has more risk & volatility, GENI or AMC?

Is GENI or AMC more profitable?

Which has preferable valuation & earnings, GENI or AMC?

Does the media prefer GENI or AMC?

Do institutionals and insiders believe in GENI or AMC?

Summary

How does GENinCode compare to Lionsgold?

Does the media prefer LION or GENI?

Which has better earnings & valuation, LION or GENI?

Do institutionals and insiders have more ownership in LION or GENI?

Is LION or GENI more profitable?

Summary

How does GENinCode compare to Sphere Medical?

Do institutionals and insiders have more ownership in GENI or SPHR?

Does the media favor GENI or SPHR?

Which has higher valuation & earnings, GENI or SPHR?

Is GENI or SPHR more profitable?

Summary

Media Sentiment Over Time

GENI vs. The Competition

GENinCode Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools